Alcon Laboratories Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
Highlights
Alcon Laboratories Inc (Alcon), a division of Novartis AG, develops and manufactures devices in the field of ophthalmology. The company’s portfolio encompasses contact lenses and surgical products. Alcon’s products are used for the treatment of various conditions such as cataracts, glaucoma, retinal diseases and refractive errors. It conducts clinical trials to evaluate the safety and efficacy of its products for prevention and cure of blindness and different eye diseases. Alcon develops its pipeline products through collaboration with leading institutions, medical innovators, research advisors, and academic thought leaders. The company has its facilities in the US, Germany, Malaysia, Singapore, Indonesia, Switzerland, Israel and Belgium. Alcon is headquartered in Fort Worth, Texas, the US.
Alcon Laboratories Inc Key Recent Developments
Jun 13, 2018: Alcon to Showcase New Products, Commitment to ECP Education and Improving Patient Outcomes at 2018 Optometry s Meeting
May 07, 2018: Alcon Cares Project 100 Commits to Reducing Cataract Blindness Globally
Mar 01, 2018: Alcon Announces Transition To New Product Packaging For AIR OPTIX Plus HydraGlyde Contact Lenses In US
Mar 01, 2018: Alcon US Vision Care Creates Innovative Patient and Practice Experience Team to Deliver Consulting Expertise to Practices
Nov 10, 2017: Alcon to Invest $97M in Georgia Expansion Project
Reasons to Buy
Note: Some sections may be missing if data is unavailable for the company.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights
Alcon Laboratories Inc (Alcon), a division of Novartis AG, develops and manufactures devices in the field of ophthalmology. The company’s portfolio encompasses contact lenses and surgical products. Alcon’s products are used for the treatment of various conditions such as cataracts, glaucoma, retinal diseases and refractive errors. It conducts clinical trials to evaluate the safety and efficacy of its products for prevention and cure of blindness and different eye diseases. Alcon develops its pipeline products through collaboration with leading institutions, medical innovators, research advisors, and academic thought leaders. The company has its facilities in the US, Germany, Malaysia, Singapore, Indonesia, Switzerland, Israel and Belgium. Alcon is headquartered in Fort Worth, Texas, the US.
Alcon Laboratories Inc Key Recent Developments
Jun 13, 2018: Alcon to Showcase New Products, Commitment to ECP Education and Improving Patient Outcomes at 2018 Optometry s Meeting
May 07, 2018: Alcon Cares Project 100 Commits to Reducing Cataract Blindness Globally
Mar 01, 2018: Alcon Announces Transition To New Product Packaging For AIR OPTIX Plus HydraGlyde Contact Lenses In US
Mar 01, 2018: Alcon US Vision Care Creates Innovative Patient and Practice Experience Team to Deliver Consulting Expertise to Practices
Nov 10, 2017: Alcon to Invest $97M in Georgia Expansion Project
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with this detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
Table of Contents
Section 1 - About the Company
Section 2 – Company Analysis
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Section 4 – Company’s Recent Developments
Section 5 – Appendix
List of Tables
List of Figures
Samples
LOADING...
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- STAAR Surgical Company
- Hoya Corp
- CooperVision Inc
- Bausch & Lomb Inc
- Abbott Medical Optics Inc